Skip to content

Effectiveness of a Nursing Practice Guideline on Quality of Life and Symptom Management in Patients with Esophageal Cancer Receiving Chemotherapy at ONCO 6 Ward, Phra Pok Klao Hospi

Effectiveness of a Nursing Practice Guideline on Quality of Life and Symptom Management in Patients with Esophageal Cancer Receiving Chemotherapy at ONCO 6 Ward, Phra Pok Klao Hospital

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260302003
Enrollment
84
Registered
2026-03-02
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer receiving chemotherapy Esophageal Neoplasms

Interventions

This intervention is a nursing practice guideline that provides symptom assessment education and supportive care for patients with esophageal cancer receiving chemotherapy. The guideline aims to impro
Experimental Behavioral,No Intervention No treatment
Nursing Practice Guideline for Esophageal Cancer,Routine Nursing Care

Sponsors

Anchalee Taveekoon(self-funded)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients Diagnosed with esophageal cancer. 2. Receiving or scheduled to receive chemotherapy. 3. Able to communicate and understand Thai language. 4. Willing to participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment or inability to communicate. 2. Unstable clinical condition that prevents participation. 3. Patients with severe complications requiring urgent medical intervention. 4. Patients who decline to participate or refuse to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Quality of Life Three weeks after the scheduled chemotherapy visit Quality of life is measured using the Thai EORTC QLQ C30. Scores are converted to zero to one hundred. The metric is the mean quality of life score and the difference between groups.

Secondary

MeasureTime frame
Symptom Severity Three weeks after the scheduled chemotherapy visit Symptom severity is measured using a CTCAE based symptom assessment form. Each symptom is graded and summarized. The metric is the mean symptom severity score and the difference between groups.

Countries

Thailand

Contacts

Public ContactAnchalee Taveekoon

Phra Pok Klao Hospital

paleerun@pnc.ac.th039325781

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026